nodes	percent_of_prediction	percent_of_DWPC	metapath
Methadyl Acetate—Disopyramide—SLC22A1—hematologic cancer	0.00943	0.297	CrCbGaD
Methadyl Acetate—Phenoxybenzamine—SLC22A1—hematologic cancer	0.00557	0.175	CrCbGaD
Methadyl Acetate—Diphenhydramine—SLC22A1—hematologic cancer	0.00467	0.147	CrCbGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—NFKBIA—hematologic cancer	0.00441	0.00455	CbGpPWpGaD
Methadyl Acetate—OPRM1—IL4-mediated signaling events—MTOR—hematologic cancer	0.00441	0.00455	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—TRH—hematologic cancer	0.00429	0.00444	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—PTPN11—hematologic cancer	0.00419	0.00433	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—CXCR4—hematologic cancer	0.00417	0.00431	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—LPAR1—hematologic cancer	0.00416	0.0043	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—FOS—hematologic cancer	0.00407	0.0042	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—CREB1—hematologic cancer	0.00406	0.0042	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CCL17—hematologic cancer	0.00406	0.00419	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CXCR5—hematologic cancer	0.00398	0.00411	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CNR2—hematologic cancer	0.00383	0.00395	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—MAP2K1—hematologic cancer	0.00378	0.0039	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—PTGER4—hematologic cancer	0.0037	0.00382	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—PIK3R1—hematologic cancer	0.00354	0.00366	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—CXCR4—hematologic cancer	0.00352	0.00364	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CCR7—hematologic cancer	0.00352	0.00363	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CXCL13—hematologic cancer	0.00352	0.00363	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL3—hematologic cancer	0.00329	0.0034	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—TRH—hematologic cancer	0.00327	0.00338	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR4—hematologic cancer	0.00327	0.00337	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—CD4—hematologic cancer	0.00326	0.00337	CbGpPWpGaD
Methadyl Acetate—Tamoxifen—ABCG2—hematologic cancer	0.00318	0.1	CrCbGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—PTGER4—hematologic cancer	0.00317	0.00327	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—LPAR1—hematologic cancer	0.00317	0.00327	CbGpPWpGaD
Methadyl Acetate—Tamoxifen—ESR1—hematologic cancer	0.00311	0.0979	CrCbGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—IL1B—hematologic cancer	0.00302	0.00311	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—JUN—hematologic cancer	0.00292	0.00302	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CNR2—hematologic cancer	0.00291	0.00301	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR4—hematologic cancer	0.0028	0.00289	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—MAPK8—hematologic cancer	0.00276	0.00286	CbGpPWpGaD
Methadyl Acetate—OPRM1—IL4-mediated signaling events—PIK3CA—hematologic cancer	0.00269	0.00277	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—RHOJ—hematologic cancer	0.00268	0.00277	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—ARHGEF12—hematologic cancer	0.00262	0.00271	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—ARHGEF1—hematologic cancer	0.00256	0.00264	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CCL3—hematologic cancer	0.00251	0.00259	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—PTHLH—hematologic cancer	0.00248	0.00256	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—MAPK3—hematologic cancer	0.00241	0.00249	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—PTGER4—hematologic cancer	0.00241	0.00249	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—IFT172—hematologic cancer	0.00239	0.00247	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—ARHGEF12—hematologic cancer	0.00238	0.00246	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—TGFB1—hematologic cancer	0.00234	0.00242	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—ARHGEF1—hematologic cancer	0.00232	0.0024	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CXCR5—hematologic cancer	0.00225	0.00232	CbGpPWpGaD
Methadyl Acetate—OPRM1—IL4-mediated signaling events—AKT1—hematologic cancer	0.00219	0.00227	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—CCL2—hematologic cancer	0.00219	0.00226	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PPEF1—hematologic cancer	0.00218	0.00226	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—GNA13—hematologic cancer	0.00217	0.00224	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—TIAM1—hematologic cancer	0.00214	0.00221	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CXCR4—hematologic cancer	0.00213	0.0022	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CCL17—hematologic cancer	0.00208	0.00215	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—JAK3—hematologic cancer	0.00207	0.00214	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CXCR5—hematologic cancer	0.00204	0.00211	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CCR7—hematologic cancer	0.00199	0.00205	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CXCL13—hematologic cancer	0.00199	0.00205	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—GNA13—hematologic cancer	0.00197	0.00204	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—TIAM1—hematologic cancer	0.00194	0.00201	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—IL3RA—hematologic cancer	0.00194	0.002	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—JAK3—hematologic cancer	0.00188	0.00194	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—RGS2—hematologic cancer	0.00187	0.00193	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—TRH—hematologic cancer	0.00185	0.00191	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—TRIO—hematologic cancer	0.00185	0.00191	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—HRAS—hematologic cancer	0.00184	0.00191	CbGpPWpGaD
Methadyl Acetate—Loperamide—ABCB1—hematologic cancer	0.00184	0.058	CrCbGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CCR7—hematologic cancer	0.00181	0.00186	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CXCL13—hematologic cancer	0.00181	0.00186	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—LPAR1—hematologic cancer	0.00179	0.00185	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—IL6—hematologic cancer	0.00177	0.00182	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—IL3RA—hematologic cancer	0.00176	0.00182	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—HDAC11—hematologic cancer	0.00173	0.00178	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—RGS2—hematologic cancer	0.0017	0.00175	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—TRH—hematologic cancer	0.00168	0.00173	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—TRIO—hematologic cancer	0.00168	0.00173	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—BCR—hematologic cancer	0.00165	0.00171	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CNR2—hematologic cancer	0.00165	0.0017	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—PDE4B—hematologic cancer	0.00165	0.0017	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—AKT1—hematologic cancer	0.00163	0.00168	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—LPAR1—hematologic cancer	0.00163	0.00168	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—RAC2—hematologic cancer	0.00162	0.00167	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—ADCY7—hematologic cancer	0.00155	0.0016	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—HDAC10—hematologic cancer	0.00154	0.00159	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—PDE4B—hematologic cancer	0.0015	0.00154	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CNR2—hematologic cancer	0.0015	0.00154	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—RAC2—hematologic cancer	0.00147	0.00152	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—hematologic cancer	0.00147	0.00151	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—ARHGEF12—hematologic cancer	0.00141	0.00145	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—ADCY7—hematologic cancer	0.00141	0.00145	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—PTHLH—hematologic cancer	0.0014	0.00145	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—ARHGEF1—hematologic cancer	0.00137	0.00142	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—PTGER4—hematologic cancer	0.00136	0.00141	CbGpPWpGaD
Methadyl Acetate—Promethazine—ABCB1—hematologic cancer	0.00133	0.0419	CrCbGaD
Methadyl Acetate—Tamoxifen—ABCB1—hematologic cancer	0.00132	0.0416	CrCbGaD
Methadyl Acetate—Methadone—ABCB1—hematologic cancer	0.00131	0.0413	CrCbGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CCL3—hematologic cancer	0.00129	0.00133	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—PTHLH—hematologic cancer	0.00127	0.00131	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—PTGER4—hematologic cancer	0.00124	0.00128	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—AGRN—hematologic cancer	0.00123	0.00127	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CCL17—hematologic cancer	0.00123	0.00127	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CXCR5—hematologic cancer	0.00121	0.00125	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CXCR4—hematologic cancer	0.0012	0.00124	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—LEF1—hematologic cancer	0.00119	0.00122	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—GNA13—hematologic cancer	0.00117	0.0012	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—IL3—hematologic cancer	0.00116	0.0012	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—TIAM1—hematologic cancer	0.00115	0.00118	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—RASGRP1—hematologic cancer	0.00112	0.00116	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CCL2—hematologic cancer	0.00112	0.00115	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—JAK3—hematologic cancer	0.00111	0.00115	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CXCR4—hematologic cancer	0.00109	0.00113	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CCR7—hematologic cancer	0.00107	0.0011	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CXCL13—hematologic cancer	0.00107	0.0011	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—IL3—hematologic cancer	0.00105	0.00109	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—NCOR2—hematologic cancer	0.00105	0.00109	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—IL3RA—hematologic cancer	0.00104	0.00107	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CRKL—hematologic cancer	0.00104	0.00107	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—RASGRP1—hematologic cancer	0.00102	0.00105	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—GRB2—hematologic cancer	0.00101	0.00104	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—RGS2—hematologic cancer	0.001	0.00104	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—TRH—hematologic cancer	0.000991	0.00102	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CMA1—hematologic cancer	0.000991	0.00102	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—TRIO—hematologic cancer	0.000991	0.00102	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—AGO2—hematologic cancer	0.00097	0.001	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—SPHK1—hematologic cancer	0.00097	0.001	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—LPAR1—hematologic cancer	0.00096	0.000992	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—HDAC9—hematologic cancer	0.00096	0.000992	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—H3F3B—hematologic cancer	0.00095	0.000982	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—GRB2—hematologic cancer	0.000917	0.000947	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CSF2—hematologic cancer	0.000903	0.000932	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PDE4B—hematologic cancer	0.000884	0.000913	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CNR2—hematologic cancer	0.000884	0.000913	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—FGF19—hematologic cancer	0.000876	0.000905	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—PRKCG—hematologic cancer	0.000871	0.0009	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—JAK1—hematologic cancer	0.000871	0.0009	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—RAC2—hematologic cancer	0.000869	0.000898	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—DKK1—hematologic cancer	0.000862	0.000891	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—STAT5B—hematologic cancer	0.000856	0.000884	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—ADCY7—hematologic cancer	0.000831	0.000858	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CSF2—hematologic cancer	0.00082	0.000846	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—IL2RA—hematologic cancer	0.000814	0.00084	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—XIAP—hematologic cancer	0.000808	0.000835	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—JAK1—hematologic cancer	0.000791	0.000817	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—PRKCG—hematologic cancer	0.000791	0.000817	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—SH2B3—hematologic cancer	0.000788	0.000813	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—SMARCA4—hematologic cancer	0.000788	0.000813	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—GZMB—hematologic cancer	0.000783	0.000808	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CTNNA1—hematologic cancer	0.000764	0.000789	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—HSPB1—hematologic cancer	0.00076	0.000785	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—EIF4EBP1—hematologic cancer	0.00076	0.000785	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CCL3—hematologic cancer	0.00076	0.000785	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PTHLH—hematologic cancer	0.000751	0.000776	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—SDC1—hematologic cancer	0.000751	0.000776	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—IL2RA—hematologic cancer	0.000739	0.000763	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PTGER4—hematologic cancer	0.000731	0.000755	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—LCK—hematologic cancer	0.000728	0.000752	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—H3F3A—hematologic cancer	0.000713	0.000737	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PRKCZ—hematologic cancer	0.000693	0.000716	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—PIK3CG—hematologic cancer	0.000678	0.0007	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PARP1—hematologic cancer	0.00067	0.000692	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—FBXW7—hematologic cancer	0.000659	0.00068	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CXCR4—hematologic cancer	0.000646	0.000667	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—HDAC2—hematologic cancer	0.000646	0.000667	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CBL—hematologic cancer	0.00063	0.00065	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—IL3—hematologic cancer	0.000623	0.000643	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—PIK3CG—hematologic cancer	0.000615	0.000636	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PTPN1—hematologic cancer	0.000612	0.000633	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—PTPN11—hematologic cancer	0.000605	0.000625	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—RASGRP1—hematologic cancer	0.000603	0.000622	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—HSP90AA1—hematologic cancer	0.000601	0.00062	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—SYK—hematologic cancer	0.000601	0.00062	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—PIK3CD—hematologic cancer	0.000596	0.000615	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CREB1—hematologic cancer	0.000586	0.000605	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—STAT1—hematologic cancer	0.000579	0.000598	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CCL2—hematologic cancer	0.000573	0.000592	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—IL6R—hematologic cancer	0.000571	0.00059	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—PIK3R1—hematologic cancer	0.000563	0.000581	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—JAK2—hematologic cancer	0.000547	0.000565	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—MAP2K1—hematologic cancer	0.000545	0.000563	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—GRB2—hematologic cancer	0.000542	0.00056	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—PIK3CD—hematologic cancer	0.000541	0.000559	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PDGFA—hematologic cancer	0.000541	0.000558	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—KITLG—hematologic cancer	0.000533	0.00055	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—STAT5A—hematologic cancer	0.000521	0.000538	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—PIK3CB—hematologic cancer	0.000519	0.000536	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CDKN2B—hematologic cancer	0.000516	0.000533	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—PIK3R1—hematologic cancer	0.000511	0.000528	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CD86—hematologic cancer	0.000499	0.000516	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—JAK2—hematologic cancer	0.000497	0.000513	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—HES1—hematologic cancer	0.000492	0.000509	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—NCOR1—hematologic cancer	0.00049	0.000506	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CSF2—hematologic cancer	0.000484	0.0005	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—FGF1—hematologic cancer	0.000484	0.0005	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—FOXO1—hematologic cancer	0.000477	0.000493	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—IL2—hematologic cancer	0.000477	0.000493	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PDGFRB—hematologic cancer	0.000476	0.000492	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—PIK3CB—hematologic cancer	0.000472	0.000487	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PDGFRA—hematologic cancer	0.000469	0.000484	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PRKCG—hematologic cancer	0.000467	0.000483	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—JAK1—hematologic cancer	0.000467	0.000483	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—IL2RA—hematologic cancer	0.000436	0.000451	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—IL2—hematologic cancer	0.000433	0.000447	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—TERT—hematologic cancer	0.000432	0.000446	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PDGFB—hematologic cancer	0.000421	0.000435	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—TSC2—hematologic cancer	0.000412	0.000425	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—FGFR3—hematologic cancer	0.000396	0.000409	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—MAPK14—hematologic cancer	0.000392	0.000405	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—ESR1—hematologic cancer	0.000385	0.000397	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—FN1—hematologic cancer	0.00038	0.000392	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—BAD—hematologic cancer	0.000375	0.000388	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—NFKBIA—hematologic cancer	0.000375	0.000388	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—NOTCH1—hematologic cancer	0.000372	0.000384	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CD80—hematologic cancer	0.000364	0.000376	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PIK3CG—hematologic cancer	0.000364	0.000376	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—KIT—hematologic cancer	0.000364	0.000376	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—NRAS—hematologic cancer	0.000364	0.000376	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PTPN11—hematologic cancer	0.000357	0.000369	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—MAPK3—hematologic cancer	0.000348	0.00036	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CREB1—hematologic cancer	0.000346	0.000357	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—BRAF—hematologic cancer	0.000342	0.000353	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CCL2—hematologic cancer	0.000339	0.00035	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—IL6R—hematologic cancer	0.000338	0.000349	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CREBBP—hematologic cancer	0.000337	0.000348	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—MAP2K1—hematologic cancer	0.000322	0.000332	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PIK3CD—hematologic cancer	0.00032	0.00033	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—PIK3CA—hematologic cancer	0.000317	0.000327	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—KRAS—hematologic cancer	0.000313	0.000323	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—FGF2—hematologic cancer	0.000306	0.000316	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PIK3R1—hematologic cancer	0.000302	0.000312	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—JAK2—hematologic cancer	0.000293	0.000303	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—PIK3CA—hematologic cancer	0.000287	0.000297	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—MDM2—hematologic cancer	0.000286	0.000296	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PIK3CB—hematologic cancer	0.000279	0.000288	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—MTOR—hematologic cancer	0.000279	0.000288	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—HRAS—hematologic cancer	0.000266	0.000275	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CDKN1B—hematologic cancer	0.000261	0.00027	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—AKT1—hematologic cancer	0.000259	0.000267	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CASP3—hematologic cancer	0.000256	0.000265	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—IL2—hematologic cancer	0.000256	0.000264	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—IL6—hematologic cancer	0.000255	0.000263	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CCND1—hematologic cancer	0.000249	0.000258	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—JUN—hematologic cancer	0.000249	0.000257	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CDKN1A—hematologic cancer	0.000241	0.000249	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PTEN—hematologic cancer	0.000241	0.000249	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—MAPK8—hematologic cancer	0.000235	0.000243	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—AKT1—hematologic cancer	0.000235	0.000243	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—EP300—hematologic cancer	0.00023	0.000237	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—SRC—hematologic cancer	0.000223	0.000231	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—VEGFA—hematologic cancer	0.000217	0.000225	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—STAT3—hematologic cancer	0.000215	0.000222	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—NRAS—hematologic cancer	0.000215	0.000222	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—MAPK3—hematologic cancer	0.000206	0.000212	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—MYC—hematologic cancer	0.0002	0.000207	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—TGFB1—hematologic cancer	0.0002	0.000206	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—KRAS—hematologic cancer	0.000185	0.000191	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PIK3CA—hematologic cancer	0.00017	0.000175	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—TP53—hematologic cancer	0.000164	0.00017	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—HRAS—hematologic cancer	0.000157	0.000162	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—IL6—hematologic cancer	0.00015	0.000155	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—AKT1—hematologic cancer	0.000139	0.000143	CbGpPWpGaD
